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Chemotaxis and the formation of suicidal neutrophil extracellular traps (suicidal NETosis) are key functions of polymorphonuclear
cells (PMNs). Neutrophil extracellular traps in particular are known to be significantly involved in the severity of inflammatory and
immunological disorders such as rheumatoid arthritis and Crohn’s disease. Therefore, detailed knowledge of PMNs is essential for
analyzing the mechanisms involved in, and developing new therapies for, such diseases. To date, no standard method to analyze
these cell activities has been established. This study used in vitro live cell imaging to simultaneously observe and analyze PMN
functions. To demonstrate this, the effects of phorbol-12-myristat-13-acetat (PMA, 0.1-10 nM), N-formylmethionine-leucyl-
phenylalanine (fMLP, 10 nM), and protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine (H7) on PMN
chemotaxis and suicidal NETosis were studied. PMA (1 nM-10 nM) resulted in significant concentration-dependent behavior in
chemotaxis and an earlier onset of maximum oxidative burst and NET formation of up to 44%. When adding H7, PMA-
triggered PMN functions were reduced, demonstrating that all three functions rely mostly on protein kinase C (PKC) activity,
while PKC is not essential for fMLP-induced PMN activity. Thus, the method here described can be used to objectively quantify
PMN functions and, especially through the regulation of the PKC pathway, could be useful in further clinical studies of
immunological disorders.
1. Introduction
Neutrophils, also known as polymorphonuclear cells
(PMNs), constitute 50–60% of human leukocytes [1]. They
are formed in the bone marrow and, once matured, enter into
the blood stream [2] and swiftly migrate through tissue to
detect low concentrations of chemoattractants. These sub-
stances enable PMNs to be the first cells to arrive at the site
of infection and destroy any potential pathogens by means
of phagocytosis, degranulation, cytokine production, and
NETosis. Therefore, PMNs are of great importance to the
immune system [3].
NETosis describes a mechanism by which a neutrophil
chromatin remodels into a net-like structure and is then
ejected into the extracellular space to form a neutrophil
extracellular trap (NET). To date, several types of NETosis
have been identified, such as suicidal [4], vital [5], and a var-
iation of the suicidal type based on mitochondrial DNA [6].
The NET consists of neutrophil DNA, histones, and pro-
teins, enabling the NET to bind and kill pathogens [7].
Apart from preventing infections, NETs also play an
important role in immunological disorders such as systemic
lupus erythematodes, Crohn’s disease, ulcerative colitis,
multiple sclerosis, and rheumatoid arthritis (RA) as well
as diabetes types 1 and 2. In most cases, the cause is either
a lack of or excessive NET formation [2]. Consequently,
detailed knowledge of how PMNs work is a key to under-
standing and curing a wide range of diseases.
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PMN plays a crucial role in the onset and progression of
RA. In RA, PMN displays increased cell survival, migration,
and inflammatory activity and enhanced NET formation,
leading to the activation of other immune cells [8]. Upon
entering the synovial cavity, rheumatoid nodules, or skin
[9], enhanced NET formation sets in. Among other pro-
cesses, the intracellular peptidylarginine deiminase 4 citrulli-
nates several peptides present on the NET before extrusion
[10]. Together with proinflammatory cytokines such as
IL17A and TNF [2], these citrullinated peptides act as extra-
cellular autoantigens. Fibroblast-like synoviocytes, which
serve as antigen-presenting cells, internalize the citrullinated
peptides and induce the formation of anti-citrullinated pro-
tein antibodies (ACPAs) [10]. After antigen recognition by
ACPAs, immune complexes form, which in turn induce fur-
ther NET formation. A continuous cycle is established, lead-
ing to joint destruction. ACPA levels are elevated in RA
patients before clinical symptoms can be observed, thus serv-
ing as an early biomarker. In addition, fibroblast-like syno-
viocytes increase the synthesis of adhesion molecules and
inflammatory cytokines such as IL-6 or IL-8, contributing
to pathogenic autoimmunity and further damage to tissue
and joints [9]. Aside from NETs, several other substances
are released into the synovia, such as B-cell activating factor
and nuclear factor kappa-b ligand, leading to excessive
immune responses in joints and tissue due to the increased
activity of B-cells and osteoclasts [2]. Therefore, targeting
neutrophil-produced cytokines, chemokines, and NET for-
mation to regulate PMN activity offers a novel therapy con-
cept towards the improvement of RA outcomes [11].
To observe PMN functions in vitro, several chemotactic
substances are used, such as pathogen-derived N-formyl-
methionine-leucyl-phenylalanine (fMLP) or host-derived
IL-8 [12, 13]. fMLP, for instance, modulates PMN adhesion
[14], microtubule polymerization [15], and activation of pro-
tein kinase C (PKC) isoforms [16] via its receptor-associated
tyrosine kinases [17]. The PKC isoforms are a group of
enzymes involved in several PMN functions. They can be
activated indirectly (fMLP) and directly through pharmaco-
logical agents such as phorbol-12-myristat-13-acetat
(PMA). After activation, PKC translocate to cell compart-
ments such as the cell membrane and are identifiable through
immunochemical studies. Five of the many PKC isoforms
have been identified in PMN so far: α, β1, β2, δ, and ζ. Each
of these isoforms contributes differently to PMN functions.
PKCβ, for example, regulates ROS production [18], whereas
PKCζ contributes to both PMNmigratory [19] and oxidative
behavior [20].
In experimental trials, no gold standard in vitro method to
analyze PMN functions such as NETosis has been found yet.
One of the most common methods in PMN research involves
the isolation of PMNs by density gradient, incubation with a
stimulus of choice, then fixation followed by immunostaining,
and lastly examination through microscopy. This process
enables a detailed study of the structures involved, depending
on the immunostaining. However, as PMNs are no longer via-
ble after fixation, the resulting analysis depicts only a single
point in time, and in most cases, this analysis is subject to
the examiner’s opinion [4].
In addition, flow cytometry is often used to investigate cell
activity. Other methods, such as fluorometry or ELISA, are
more applicable in a clinical setting and, similar to micros-
copy, can identify NET components. The drawback is that nei-
ther method is able to determine the origin of the component,
and the amount of the component is not measured over time
but accumulated up to the point of detection [21].
Each of the methods stated here has its advantages and
disadvantages, meaning it is up to the researchers to decide
which method is the most suitable for their investigation. Live
cell imaging [12, 22] uses viable neutrophils with the possibil-
ity of cell observation over any length of time and using any
desired stimulus. With further development, this method
could become the new gold standard, combining its advan-
tages with solutions to the disadvantages of former methods.
This study is aimed at
(1) demonstrating a method that enables the objective
and simultaneous observation of motility and cell
activities of viable PMNs over a longer period of time
by using live cell imaging
(2) delivering quantitative results on the effects of fMLP,
PMA, and H7 on PMN migration, oxidative activity,
and formation of neutrophil extracellular traps to
further understand PMN behavior and provide
insight for potential clinical application
2. Material and Methods
2.1. PMN Isolation. Peripheral blood was drawn from healthy
donors using Safety-Multifly-cannula (0:8 × 19mm), safety-
cannula (0:9 × 38mm), and S-Monovettes containing lith-
ium heparin (Li-Hep (16 IE/mL blood); all equipment above
is from Sarstedt AG & Co, Nümbrecht, Germany) according
to a protocol approved by the ethics committee (No.15-101-
0043) at the University of Regensburg (Germany). PMNs
were isolated using density gradient centrifugation based on
the protocol provided by pluriSelect Life Science using Leu-
koSpin and LymphoSpin solutions (pluriSelect Life Science,
Leipzig, Germany) [23]. The cells were then resuspended in
RPMI 1640 medium (Sigma Aldrich, Steinheim, Germany)
at a concentration of 18 × 106 cells/mL. PMNs were stained
using 4′,6-diamidino-2-phenylindole (DAPI, Sigma Aldrich
Chemie Ltd., St. Louis, USA) to mark extracellular DNA
and dihydrorhodamine-123 (DHR-123, Molecular Probes,
Inc., Eugene, USA) to detect reactive oxygen species (ROS).
Both markers were initially diluted with Dimethylformamide
(DMF) and Dulbecco’s phosphate-buffered saline (DPBS,
both from Sigma Aldrich, Steinheim, Germany), followed
by RPMI 1640 medium with 10% fetal calf serum (FCS,
Sigma Aldrich, Steinheim, Germany) to reach their final con-
centrations of 50ng/mL and 10nM, respectively.
2.2. Stimulation. All stimulants and isoquinoline-5-sulfon-2-
methyl-1-piperazide (H7, Sigma Aldrich, Steinheim, Ger-
many) in a hydrochloride solution (Honeywell Fluka, Seelze,
Germany) were diluted using RPMI 1640 medium with 10%
FCS. N-Formyl-methionine-leucyl-phenylalanine (fMLP,
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Sigma Aldrich Chemie Ltd., St. Louis, USA) was diluted to its
final concentration of 10 nM, whereas H7 was applied at final
concentrations between 25μM and 8mM. Phorbol-12-myri-
stat-13-acetat (PMA, Sigma Aldrich Chemie Ltd., St. Louis,
USA) was used at final concentrations of 0.1, 1, 3, 10, 80,
and 100 nM.
2.3. IBIDI-Slide Preparation. 24 hours prior to each observa-
tion, the μ-Slide chemotaxis (IBIDI-Slide, IBIDI Ltd., Pla-
negg, Germany) was stored in an incubator at 37°C and 5%
CO2. Each IBIDI-Slide consists of three chambers, with each
chamber consisting of a central channel and a reservoir on
each side. Cell medium was prepared in advance using
60μL Minimum Essential Media (MEM, PAN-Biotech Ltd.,
Aidenbach, Germany), 60μL H2O, 30μL sodium hydrogen
carbonate (1M, NaHCO3, VWR International Ltd., Radnor,
Pennsylvania, USA), and 150μL RPMI 1640 and kept in
the incubator next to the IBIDI-Slide. The PureCol Type I
Bovine Collagen Solution (collagen, 3mg/mL, Advanced Bio-
Matrix Carlsbad, USA) was at room temperature when used.
H7 was added to the PMN solution and incubated for 15
minutes before the addition of other solutions. 50μL of the
prepared PMN solution, 100μL of cell medium, 30μL
PMA, and 150μL collagen were combined. 7μL of this
mixture was used to fill the central channels of an IBIDI-
Slide. Each channel contained a different concentration of
PMA, with one channel serving as a control. The IBIDI-
Slide was then incubated for 30 minutes at 37°C and 5%
CO2. Afterward, the right reservoir of each chamber was
filled with 65μL of RPMI 1640 and 10% FCS, whereas the
left reservoir contained 65μL of fMLP (10nM in
RPMI/10% FCS). The IBIDI-Slide was then sealed and
inserted into a Leica DMi8 microscope (Leica Mikroskopie
& Systeme Ltd., Wetzlar, Germany).
2.4. Microscopy. Live cell imaging was done at 30-second time
intervals for a total duration of 4.5 hours using a Leica
DFC9000 GT camera (Leica Mikroskopie & Systeme Ltd.,
Wetzlar, Germany), a CoolLEDpE4000 light source
(CoolLED Ltd., Andover, Great Britain), and Leica Applica-
tion Suite X Software (LAS X 3,0,4,16529, Leica Mikroskopie
& Systeme Ltd., Wetzlar, Germany). A dual filter cube
(Chroma Technology Corp., Vermont, USA) with the follow-
ing characteristics was used: excitation windows between
380-410 nm and 472-498 nm, dichroic filters at 418nm and
502nm, and emission windows between 424-460 nm and
505-545 nm.
2.5. Image Analysis. Images were analyzed using IMARIS
9.02 Software (Bitplane, Zurich, Switzerland). The IMARIS
“Surface” tool measured ROS production and NET formation
according to the changes in rhodamine-123 andDAPI fluores-
cence, respectively. The development of ROS production was
quantified by calculating the time of maximal ROS production
(tmaxROS) in minutes. NET formation is described as
ET50NETs in minutes, which is the time point of half-
maximum effect of NET formation reached during the exper-
iment. The sufficiency of analyzing time-resolved DAPI stain-
ing for NETosis identification has already been proven [22,
24]. The “Spots” tool tracked each cell movement for the entire
period of observation. Track length, track displacement along
the x-axis and y-axis (TDX, TDY), and the directness were
measured to describe migratory behavior. D describes migra-
tion efficiency and takes values between 0 and 1. The 1 value
corresponds to straight migration as the Euclidean distance
matches the accumulated track length, whereas a value close
to 0 is equal to a migration in which the track length is far
greater than the Euclidean distance. All migration parameters
were grouped in 30-minute intervals before statistical analysis.
2.6. Statistical Analysis. IBM SPSS Statistics 22 Software was
used for statistical analysis. Data are presented as means ±
SEM or median with confidence interval, depending on the
distribution. When normal distribution was present, para-
metric tests (Student t-test, post hoc analysis) were applied,
whereas nonparametric tests (Mann-Whitney U test,
Kruskal-Wallis test) were applied when normal distribution
could not be achieved despite data transformation. The
Pearson correlation was conducted once significance was
proven. P values below 0.05 were considered significant if
not stated otherwise.
3. Results
3.1. Chemotaxis Is Dependent on PMA Concentration. TDX
decreased significantly from 44.8μm (SD 44.6μm, n = 8,
0 nM PMA) to 0.6μm (SD 2.13μm, n = 14, 10 nM PMA)
over 30–60 minutes of observation in the presence of PMA
(see Figure 1(a)). TDY, by contrast, fluctuated at the zero
value with and without PMA (see Figure 1(b)).
The same concentration-dependent behavior was seen
with a track length decrease of 79.2% from 211.7μm (SD
90.6μm, n = 8, 0 nM PMA) to 44.1μm (SD 12.7μm, n =
14, 10 nM PMA) during 30–60 minutes of observation in
the presence of PMA (see Figure 2(a)). When comparing
PMA concentrations below 1nM (n = 19) and those higher
than 3nM PMA (n = 26), a significant decrease in track
length (see Figure 2(a)) was observed for each time frame
measured, ranging from 79.2 to 55.8% (10nM PMA) and
62.0 to 71.4% (3 nM PMA). There was a similar significant
decrease in directness by 73.3–71.4% (see Figure 2(b)) dur-
ing 30–90 minutes of observation when comparing 10nM
(n = 14) and 0.1 nM (n = 11) PMA. Once chemotaxis
ceased, increased ROS production inside the PMNs was
observed in the video footage. During this process, mor-
phological changes took place, followed by a rupture of
the cell membranes, thus extruding the PMNs’ DNA into
the extracellular space.
3.2. Time of Maximal ROS Production and NET Formation
Are Dependent on PMA Concentration. tmaxROS decreased
by up to 64.3% (10nM PMA, n = 14) in a PMA
concentration-dependent manner. Comparisons of 10nM
with none, 0.1, or 1 nM PMA (P < 0:001) and comparisons
of 3 nM (n = 12) and 0 nM (n = 17) or 10 nM PMA (n = 14)
showed a significant impact on tmaxROS (see Figure 3(a)).
ET50NETs (see Figure 3(b)) decreased significantly (n = 13)
by a mean value of 85.2 minutes with 10 nM PMA




















































Figure 1: Track displacement decreases during time-lapse and PMA. x-axis: 30-minute time intervals tMigration (min) in minutes, y-axis: (a)
mean track displacement along the x-axis TDX in μm; (b) mean track displacement along the y-axis TDY (μm) in μm; comparing different
PMA concentrations (0–10 nM); ∗significant when compared to 0 nM and 0.1 nM PMA; ∗∗significant when compared to 0 nM PMA; error



















































Figure 2: Track length and directness decrease during time-lapse and PMA. x-axis: 30-minute time intervals tMigration (min), y-axis: (a)
mean track length (μm) in μm, comparing different PMA concentrations (0–10 nM); (b) mean directness, comparing different PMA
concentrations (0–10 nM); ∗significant when compared to 10 nM PMA; ∗∗significant when compared to 3 nM and 10 nM PMA; error
bars represent standard deviation of measurements.
4 Journal of Immunology Research
stimulation compared to the control. The Pearson correla-
tion was significant (P < 0:001) for PMA-dependent
decreases of tmaxROS and ET50NETs parameters with nega-
tive coefficients at -0.745 and -0.523, respectively.
3.3. H7 Inhibits fMLP- and PMA-Induced Chemotaxis. PKC
inhibitor H7 (n = 17) significantly decreased fMLP-induced
migration (see Figure 4) in track length, TDX, and directness,
nearly halting any observable movement.
Track length decreased by a mean value of 35.6-68.7%,
depending on the time frame observed. However, the addi-
tion of H7 to fMLP- and PMA-induced chemotaxis (n = 5,
see Figure 4) did not show any significant effect when com-
pared to the control group (n = 14).
3.4. H7 Inhibits PMA but Not fMLP-Induced ROS Production
or NET Forming. H7 did not have any significant impact on
fMLP (n = 15)-induced tmaxROS or ET50NETs, whereas
PMA-induced tmaxROS (P < 0:001) and ET50NETs were
pushed back by mean values of 38.2 minutes (n = 5) and
23.3 minutes (n = 5), respectively, when adding H7 in this
setting (see Figure 5).
3.5. PMNs Show a Specific Stimulus-Dependent Time
Sequence. The following sequence of cellular behavior was
observed in all test groups, with differences only in the dura-
tion of each phase (see Figure 6): in the first part of the phase
contrast footage, PMN migration along the fMLP gradient
was detected. ROS production was initiated, and by the time
the PMNs stop migrating, ROS formation had reached its
peak, indicated by increased rhodamine-123 production.
The then nonmigrating PMNs underwent morphological
changes. The cell nuclei swelled, and the membranes burst,
setting the NET free. This process was made visible through
DAPI intercalation.
4. Discussion
The results reported in this study were achieved by applying a
method involving live cell imaging. This cell set-up allows the
investigator to vary direct stimuli as well as directional che-
moattraction in any manner desired and to analyze these
objectively using a single set-up. This is a great advantage
when compared to earlier studies which solely involved flow
cytometry to analyze PMN behavior [21]. In addition, simul-
taneous observation enables a comparison of each activity in
relation to each other. Doblinger et al. used the same method
described here while adding tagged MPO antibodies as an
additional marker to stain NETs. As both DAPI and MPO
were simultaneously observed and colocated, it was proven
that this method is sufficient to observe NETosis. Therefore,
only DAPI staining was used in this study to analyze NET
formation [22].
Being able to study important PMN functions such as
migration and NETosis simultaneously can provide insight
into the complex cell mechanisms involved, as will be dis-
cussed in the following.
4.1. Chemotaxis in the Presence of fMLP, PMA, and Protein
Kinase C Inhibitor H7. This study confirms typical fMLP-
induced migratory behavior [25]. The method’s set-up guar-
antees a sufficient separation of the two reservoirs through
the middle channel filled with a PMN-infused collagen
matrix. With one of the two separate reservoirs containing
only medium/FCS as a control, the investigator is able to
assess the ability of fMLP as a chemoattractive substance
through observation of directional migration to one side of
the chamber. This is a great advantage over the Dunn cham-
ber assay [3], in which cells are fully surrounded by a che-
moattractant gradient at all times. In this study, PMNs
clearly showed a migration along the positive x-axis towards
the fMLP reservoir without major diversion along the y-axis.
Moonen et al. observed a similar fMLP-directed migration
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Figure 3: Point of time of ROS production and half-maximal NET formation decrease during PMA exposition. x-axis: PMA (nM)
concentration in nM; y-axis: (a) mean time of maximal ROS formation tmaxROS (min) in min; (b) mean time of half-maximal NET
formation ET50NETs in minutes;
∗significant compared to 3 nM and 10 nM PMA; ∗∗significant (P < 0:05) compared to 10 nM PMA; error
bars represent standard deviation of measurements.
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using 15 nM fMLP with PBS as controls in Insall chambers.
Values for migration directness, however, differed slightly
during the first period of observation [26]. This can be
explained by the differences in fMLP concentration and the
time frame observed. Adding the PKC inhibitor H7 to
fMLP-stimulated PMNs led to a decrease in most migration
parameters. The results suggest that PKC plays an important
role in fMLP-induced chemotaxis, which coincides with pre-
vious findings [27, 28]. Paclet et al. used Ro-31-8220 as a
PKC inhibitor and observed a decrease in fMLP-induced
(10 nM and 10μM) chemotaxis as well [29]. Despite using

























































Figure 4: Chemotaxis decreases during H7 exposition. x-axis: 30-minute time intervals tMigration (min), y-axis: (a) mean track length in μm;
(b) mean track displacement along the x-axis TDX in μm; comparing groups with and without H7; ∗significant (P < 0:05) compared to the















































Figure 5: Delayed onset of oxidative activity and NET formation triggered by fMLP+PMA during H7 exposition. x-axis: cell groups
stimulated using fMLP or fMLP and PMA; y-axis: (a) mean time of maximal ROS formation tmaxROS in min; (b) mean time of half-
maximal NET formation ET50NETs in min;
∗significant (P ≤ 0:001) compared to the control group without H7; error bars represent
standard deviation of measurements.
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studies stated above, PKC seems to be imperative for fMLP-
induced migration.
Surprisingly, H7 had hardly any effect on PMNmigration
in the presence of PMA, which contradicts previous observa-
tions [27]. Assuming that H7 and PMA are not restricted in
their functions, two theories could explain this observation.
Firstly, the H7 concentrations used were too low, and sec-
ondly, the migration observed was already at its minimum
upon PMA exposure without adding H7. The latter being
the case, no change would be seen when H7 was added to
the exhausted PMN. With regard to all migration parame-
ters, this second theory is considered the more likely explana-
tion. Thus, fMLP- and/or PMA-triggered migration is
dependent on PKC and can be regulated using the PKC
inhibitor H7. There are also other substances capable of
modulating PMN migration. Applying the same method
described in this paper, PMN migration could either be
decreased or increased using substances such as therapeutic
anticoagulants [24] or IL-8 [12], respectively. This highlights
the advantage of this method’s approach: several conditions
can be observed simultaneously for comparison.
4.2. Oxidative Activity and NET in the Presence of fMLP,
PMA, and H7. Once migration came to a halt, oxidative
activity sets in. When exposed solely to fMLP (10nM), tmax
ROS peaked at 90 minutes. This suggests that PMN migra-
tion and NETosis were triggered by fMLP (10nM) alone.
Briheim et al. used 100nM fMLP in their experiments,
which resulted in peaks at two and ten minutes. This differ-
ence in results can be explained by the differences in methods
and concentration of fMLP used. Briheim et al. were observ-
ing the development of ROS chemiluminescence [30],
whereas the area of ROS producing PMNs over time was
observed in this study.
H7 showed no effect on fMLP-induced ROS formation or
NETosis. This coincides with a study by Klink et al., in which
H7 (100μM) did not have any impact on ROS formation
triggered by fMLP in fluorometry [17]. However, previous
studies have also shown that fMLP is in fact involved in
PKCα, β, and ζ [20] translocation leading to ROS produc-
tion. This suggests that either H7 is incapable of inhibiting
fMLP-induced PKC activity or fMLP can also activate ROS
production in a PKC-independent way. The latter seems
more likely because fMLP is closely associated with G-
protein coupled pathways, which can lead to ROS production
independent of direct PKC activation [31]. In addition, H7
showed an effect on ROS formation and NETosis when the
direct PKC activator PMA was present. Kilpatrick et al. attri-
bute the PKCδ as playing an initiating role for PMA-induced
but not fMLP-induced ROS formation [32]. Other studies
state that PKCα and PKCβ are essential for both fMLP-
and PMA-associated ROS formation [16]. This makes it less
likely that H7 is incapable of inhibiting fMLP-induced PKC
activity. We therefore suggest that fMLP-triggered PMN
functions are linked to PKC isotypes but are able to coopt
alternative fMLP-sensitive signal pathways for ROS forma-
tion. This does not apply to PMA-triggered oxidative activity
as this has been shown to be susceptible to H7 [33].
Regarding NETosis, ET50NETs did not prove to be
affected by H7 in a statistically significant way. However,
when comparing the ET50NETs values in the H7 group and
the control group, there was a noticeable difference. Taking
into consideration the steady correlation of ROS formation
and NET formation in the first series of experiments, and
the work of Alemán et al. stating that the inhibition of PKC
also delays NET formation [34], a correlation between
PMA-induced NET formation and H7 seems likely. From a
clinical point of view, it can be suggested that reducing
PKC activity in PMN could be of therapeutic use in contain-
ing immunological disorders such as rheumatoid arthritis.
Otherwise, elevated PMN activity can lead to excessive oxida-
tive activity and NET formation, thus causing further joint
deterioration [35].
4.3. Concentration-Dependent Effect of PMA on Chemotaxis.
In this study, we also analyzed the concentration-dependent
effect of PMA on PMN functions. Here, migration showed
a decrease during PMA exposure above 1 nM. This observa-
tion leads to two hypotheses: firstly, PMA inhibits migration,
and secondly, it elevates cell activation. Elevated cell activity
would result in an early onset of migration, oxidative activity,
and NET formation in accordance with the stimulus used.
An early study by Boonen et al. showed a concentration-
dependent increase of migration using 0–0.1 nM PMA. This
suggests an elevated migratory activity, after stimulation with
PMA in low concentrations, similar to the findings in this
study (see TDX development in Figure 1). Higher concentra-
tions were thought to be inhibitory to migration [36], sup-
porting the first theory. However, bearing in mind the
constant sequence of PMN behavior across all test groups,
an inhibition of migration seems highly unlikely. Instead, it
is here considered that PMA-triggered elevated cell activa-
tion was the cause of an early and intense migration followed
by the early onset of oxidative activity and NET formation
observed in this study.
4.4. Concentration-Dependent Effect of PMA on ROS
Production and NET Formation. PMA-induced oxidative
activity tmaxROS peaked between 60 and 120 minutes after
PMA exposure in a concentration-dependent manner.
0 30 60 90 120 150 180
Time (min)
Figure 6: Live cell imaging: time flow in min of a PMN treated with fMLP and H7 showing chemotaxis (phase-contrast), oxidative activity
(red, rhodamine-123, staining reactive oxygen species (ROS)), and suicidal NETosis (blue, DAPI, staining PMN–DNA (NET)).
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Looking at PMA concentrations from 1nM to 10nM, it was
seen that a threefold concentration led to an earlier onset of
tmaxROS by 25-30 minutes. These results suggest a linear cor-
relation between PMA concentration and tmaxROS at a low
concentration range. Other studies have shown a similar
peak time for oxidative burst when using a much higher con-
centration of PMA (50 nM [37], 100 nM [30]). Two hypoth-
eses can be deduced: Firstly, tmaxROS is dependent on PMA
concentration, but probably not in a linear manner. Sec-
ondly, PMA-triggered PMN functions show a ceiling effect:
PMN activation is already saturated and has reached its max-
imum when exposed to lower PMA concentrations (e.g.,
50 nM), thus triggering intracellular activities which take at
least 20 minutes to show maximal effect. This could explain
why different studies state similar maximal oxidative activity
peak times while using highly different PMA concentrations.
It should be kept in mind that PMA concentrations below
1nM did not show any significant effect on PMN oxidative
activity compared to the control group. In this study, a min-
imum stimulus of 1-3 nM PMA for at least 30 minutes
seemed to be necessary to trigger the intracellular cascade.
However, Bonnekoh et al. observed an increased number of
NETs in patients with Schnitzler’s syndrome, an autoim-
mune disorder, when using a much lower concentration of
PMA (0.05 nM) for 130 minutes [38]. This suggests that
much lower concentrations could be sufficient to trigger high
NET formation in patients with autoimmune disorders, thus
rendering them susceptible to exacerbation from low stimuli.
This could explain increased rates and acceleration of NETo-
sis in autoimmune disorders such as rheumatoid arthritis [9]
and psoriasis [39].
Furthermore, live cell imaging shows that ROS formation
has to take place before the NET is extruded. This is in accor-
dance with the work of Kenny et al. [37]. In addition, both
tmaxROS and ET50NETs show PMA-dependent behavior,
which a Pearson correlation confirms, with tmaxROS being
distinctly more sensitive to changes in PMA concentration
compared to ET50NETs.
Therefore, the concentration and duration of the stimula-
tion and observation have to be taken into consideration when
assessing stimulus-dependent PMN activity, especially in a
clinical setting. Further evaluation as described in this study
of PMN activities in vitro, using human blood of the healthy
and the diseased, is needed. This is necessary in order to
develop new therapy concepts for immunological disorders.
5. Conclusion
PMN migration, ROS production, and NET formation are
triggered by chemotactic substances such as fMLP (10nM).
This behavior can be influenced by PMA. During PMA expo-
sure (0.1–10nM), PMN activity levels increase in a
concentration-dependent manner, leading to an early onset
of tmaxROS and ET50NETs.
All three PMN functions observed are dependent on
the PKC activity in the presence of PMA. In the absence
of PMA, PKC dependency also applies to fMLP-triggered
migration, but not fMLP-triggered ROS formation or
NET formation.
The regulation of PKC activity in patients with immuno-
logical diseases such as rheumatoid arthritis could offer a new
therapeutic concept to contain the disease.
In addition, using live cell imaging as described in this
paper allows the investigator to vary stimuli and chemoat-
tractants in any manner desired, thus providing insight into
complex cell mechanisms in PMN. The investigation of
PMN involvement in various diseases, as well as in pharma-
cological testing, is feasible by means of the live cell imaging
described in this study. Using LASX and Imaris Software
allows objective data acquisition and analysis. We believe this
approach to be suitable for future PMN research in immuno-
logical disorders.
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